NDC 51991-312 – Desvenlafaxine

Desvenlafaxine Succinate 100 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC51991-312

Product details

Brand name
Desvenlafaxine
Generic name
Desvenlafaxine Succinate
Labeler
Breckenridge Pharmaceutical, Inc
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204003
Marketed since
March 1, 2017
Listing expires
December 31, 2027
Pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Desvenlafaxine →

Package NDC codes (7)

Package NDCDescriptionSince
51991-312-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-01)Mar 1, 2017
51991-312-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-10)Mar 1, 2017
51991-312-11100 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-11)Mar 1, 2017
51991-312-1414 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-14)Mar 1, 2017
51991-312-3330 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-33)Mar 1, 2017
51991-312-8080 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-80)Mar 1, 2017
51991-312-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-90)Mar 1, 2017

Other Desvenlafaxine products